Similar articles

• Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.

  [No authors listed] [No authors listed] Diabetes Technol Ther. 2000 Summer;2(2):292. Diabetes Technol Ther. 2000. PMID: 11469275 No abstract available.
• Warner-Lambert voluntarily withdraws Rezulin.

  [No authors listed] [No authors listed] Diabetes Technol Ther. 2000 Summer;2(2):290. Diabetes Technol Ther. 2000. PMID: 11469273 No abstract available.
• Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.

  [No authors listed] [No authors listed] Diabetes Technol Ther. 2000 Summer;2(2):290-1. Diabetes Technol Ther. 2000. PMID: 11469274 No abstract available.
• Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.

  Kohlroser J, Mathai J, Reichheld J, Banner BF, Bonkovsky HL. Kohlroser J, et al. Am J Gastroenterol. 2000 Jan;95(1):272-6. doi: 10.1111/j.1572-0241.2000.01707.x. Am J Gastroenterol. 2000. PMID: 10638596 Review.
• [Thiazolidindiones in type II diabetes mellitus].

  Bornkessel B. Bornkessel B. Med Monatsschr Pharm. 1998 Mar;21(3):66-8. Med Monatsschr Pharm. 1998. PMID: 9556974 Review. German. No abstract available.